Kunming Longjin Pharmaceutical Co Ltd (002750) — Strategic Asset Allocation Index
Kunming Longjin Pharmaceutical Co Ltd (002750) has a Strategic Asset Allocation Index of 31.6% as of September 2023. Strategic assets (PP&E of CN¥184.25 Million plus long-term investments of CN¥-) total CN¥184.25 Million, measured against net assets of CN¥582.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Kunming Longjin Pharmaceutical Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Kunming Longjin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of September 2023, the index stands at 31.6%, representing strategic assets of CN¥184.25 Million against net assets of CN¥582.16 Million CNY. Explore how efficiently does Kunming Longjin Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Kunming Longjin Pharmaceutical Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Kunming Longjin Pharmaceutical Co Ltd (002750) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.5% | CN¥202.48 Million | CN¥202.48 Million | CN¥- | CN¥604.77 Million | ▲ +0.6 pp |
| 2021 | 32.9% | CN¥223.25 Million | CN¥223.25 Million | CN¥- | CN¥678.29 Million | ▼ -1.1 pp |
| 2020 | 34.0% | CN¥239.53 Million | CN¥239.53 Million | CN¥- | CN¥704.71 Million | ▼ -2.4 pp |
| 2019 | 36.4% | CN¥242.36 Million | CN¥242.36 Million | CN¥- | CN¥665.89 Million | ▼ -2.4 pp |
| 2018 | 38.8% | CN¥254.22 Million | CN¥230.52 Million | CN¥23.70 Million | CN¥655.93 Million | ▼ -3.5 pp |
| 2017 | 42.3% | CN¥272.95 Million | CN¥245.65 Million | CN¥27.30 Million | CN¥645.54 Million | ▲ +0.7 pp |
| 2016 | 41.6% | CN¥279.01 Million | CN¥247.66 Million | CN¥31.35 Million | CN¥670.46 Million | ▼ -2.0 pp |
| 2015 | 43.6% | CN¥261.61 Million | CN¥261.61 Million | CN¥- | CN¥599.41 Million | ▼ -54.1 pp |
| 2014 | 97.7% | CN¥279.08 Million | CN¥279.08 Million | CN¥- | CN¥285.57 Million | ▼ -1.3 pp |
| 2013 | 99.1% | CN¥299.18 Million | CN¥299.18 Million | CN¥- | CN¥302.00 Million | ▲ +3.1 pp |
| 2012 | 95.9% | CN¥217.69 Million | CN¥217.69 Million | CN¥- | CN¥226.94 Million | ▲ +21.0 pp |
| 2011 | 74.9% | CN¥139.83 Million | CN¥139.83 Million | CN¥- | CN¥186.74 Million | — |